Orthopedic Surgery Doctors in Alhambra, CA Accepting Medicare

10 Orthopedic Surgery doctors found. Showing 1 - 10

Anthony P. Yang, M.D Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 707 S Garfield Ave, Alhambra, CA 91801 Phone: 626-458-6653    Fax: 626-289-5700

Jonathan Chang, M.D Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 707 S Garfield Ave, Alhambra, CA 91801 Phone: 626-458-6653    Fax: 626-289-5700

Dr. Mark S. Hsiao, M.D. Orthopaedic Surgery - Orthopaedic Surgery of the Spine Medicare: Accepting Medicare Assignments Practice Location: 707 S Garfield Ave Fl 2, Alhambra, CA 91801 Phone: 626-282-1600    Fax: 626-656-1264

Alan H Lee, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 707 S Garfield Ave Fl 2, Alhambra, CA 91801 Phone: 626-282-1600    Fax: 626-656-1264

David W.p. Huang, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 707 S Garfield Ave, Suite 201, Alhambra, CA 91801 Phone: 626-458-6653    Fax: 626-289-5700

Benjamin C. Tam, M.D Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 707 S Garfield Ave, Alhambra, CA 91801 Phone: 626-458-6653    Fax: 626-289-5700

Yen Hsun Chen, MD Orthopaedic Surgery - Hand Surgery Medicare: Accepting Medicare Assignments Practice Location: 707 S Garfield Ave, Alhambra, CA 91801 Phone: 626-282-1600

Vu Hoan Le, MD Orthopaedic Surgery - Foot and Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 707 S Garfield Ave Fl 2, Alhambra, CA 91801 Phone: 626-282-1600    Fax: 626-656-1264

Shane S Pak, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 707 S Garfield Ave, Ste. 201, Alhambra, CA 91801 Phone: 626-656-1324    Fax: 626-656-1264

Matthew Y.c Lin, M.D Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 707 S Garfield Ave, Alhambra, CA 91801 Phone: 626-458-6653    Fax: 626-289-5700

News Archive

Study points to potential new therapeutic target for preventing birth defects in women with diabetes

A research team at the University of Maryland School of Medicine has identified a cell signaling pathway which plays a significant role in causing developmental defects of the fetal spinal cord and brain in babies of women with diabetes.

Leadiant Biosciences announces FDA approval of Revcovi for treating pediatric, adult ADA-SCID patients

Leadiant Biosciences, Inc. today announced that the Food and Drug Administration has granted approval to Revcovi (elapegademase-lvlr) injection in the U.S. Revcovi is a new enzyme replacement therapy for the treatment of adenosine deaminase severe combined immune deficiency in pediatric and adult patients.

Vicept completes $16 million Series A financing

Vicept™ Therapeutics Inc., a privately held specialty biopharmaceutical company dedicated to developing the first effective topically applied therapy for erythema (facial redness) of rosacea, announced that it has secured $10 million to complete a total $16 million Series A financing. The Series A was led by Vivo Ventures, Sofinnova Ventures and Fidelity Biosciences.

Family planning should be 'cornerstone' of U.S. policy in Afghanistan

"Without attention to population, countries like Afghanistan and Pakistan stand a good chance of staying mired in poverty, conflict, and corrupt, repressive government. That is why sustained investment in family planning by the United States and other countries would do more to stabilize the political climate there than any other foreign-policy initiative," Jennifer Dabbs Sciubba, former Defense Department consultant and the Mellon Environmental Fellow in the department of international studies at Rhodes College, writes in a Philadelphia Inquirer opinion piece.

Read more Medical News

› Verified 7 days ago